COVID-19: Covaxin trial on children aged 12-18 years in Nagpur shows positive signs
No side effects were observed in the children who participated in the Nagpur Center Vaccination Trial even after 1 week. On June 6, 40 volunteers were given the first dose of the Covaxin.
